Bayer CropScience Ltd
NSE: BAYERCROP BSE: 506285
₹4520.60
(-1.82%)
Thu, 12 Mar 2026, 11:29 am
Market Cap206.93B
PE Ratio30.31
Dividend2.71
Process Industries
Chemicals: Agricultural
24.5KBayer CropScience Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (4.2x coverage).
- Dividends per share have been stable in the past 10 years.
- Bayer CropScience's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Bayer CropScience's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Bayer CropScience is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Bayer CropScience is profitable, therefore cash runway is not a concern.
- Bayer CropScience is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (44393.3%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 2009.6x debt.
- Bayer CropScience's cash and other short term assets cover its long term commitments.
- Interest payments on debt are well covered by earnings (EBIT is 47.9x coverage).
- Bayer CropScience's level of debt (0.1%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The average tenure for the Bayer CropScience board of directors is less than 3 years, this suggests a new board.
- Duraiswami's remuneration is higher than average for companies of similar size in India.
- The average tenure for the Bayer CropScience management team is less than 2 years, this suggests a new team.
misc
- Bayer CropScience is not covered by any analysts.
- Bayer CropScience has significant price volatility in the past 3 months.
past
- Bayer CropScience's 1-year earnings growth exceeds its 5-year average (100.5% vs -5.1%)
- Bayer CropScience used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Bayer CropScience has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Bayer CropScience's earnings growth has exceeded the IN Chemicals industry average in the past year (100.5% vs 9.1%).
- Bayer CropScience's year on year earnings growth rate was negative over the past 5 years, however the most recent earnings are above average.
- Bayer CropScience has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
- 506285 outperformed the Chemicals industry which returned 2.2% over the past year.
- 506285 outperformed the Market in India which returned -14.5% over the past year.
- BSE:506285 is up 25.9% outperforming the Chemicals industry which returned 6.9% over the past month.
- BSE:506285 is up 25.9% outperforming the market in India which returned 8% over the past month.
- Bayer CropScience's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Bayer CropScience's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Bayer CropScience is overvalued based on assets compared to the IN Chemicals industry average.
- Bayer CropScience is overvalued based on earnings compared to the IN Chemicals industry average.
- Bayer CropScience is overvalued based on earnings compared to the India market.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800